Bajaj HealthCare Quarterly Results for Trading Insights
BAJAJHCARE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹43 Cr
QMarch 2025
Bajaj HealthCare Quarterly Results Key Highlights
- Revenue of ₹562 Cr in March 2025 (+0.0% vs March 2025, +16.6% vs March 2024)
- Net Profit of ₹43 Cr in March 2025 (+0.0% vs March 2025, +407.1% vs March 2024)
- EBITDA of ₹102 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 15.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹13.29 in March 2025 (+0.0% vs March 2025)
Bajaj HealthCare Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 630 | 562 | 482 | 647 | 681 | 12.1% | - |
| Net Profit (₹ Cr) | 50 | 43 | -14 | 64 | 71 | - | - |
| EBITDA (₹ Cr) | 109 | 102 | 85 | 113 | 120 | - | - |
| EPS (₹) | 15.80 | 13.29 | -30.36 | 15.59 | 25.87 | - | - |
| Operating Margin (%) | 15.0% | 15.0% | 16.0% | 17.0% | 17.0% | - | - |
Bajaj HealthCare Share Price Trend Around Quarterly Results
Visualize Bajaj HealthCare's 1-year price movement across quarterly results — ideal for logging trades in Bajaj HealthCare share price
chart using Tickjournal. All values in ₹.
Related Pages for Bajaj HealthCare
Additional stock information and data for BAJAJHCARE
Revenue Trend (₹ Cr)
March 2023
647
March 2024
482
March 2025
562
2026
630
Net Profit Trend (₹ Cr)
March 2023
64
March 2024
-14
March 2025
43
2026
50
Operating Margin Trend (%)
March 2023
17.0%
March 2024
16.0%
March 2025
15.0%
2026
15.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Bajaj HealthCare quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹409,614.47 Cr | 1704.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.1 |
|
Divis Laboratories
Sept 2025 |
₹159,931.55 Cr | 6113.5 | 2,860 | 689 | +7.1% | - | 24.1% | 235.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹133,313.66 Cr | 3997.2 | 3,219 | 591 | +11.3% | - | 18.4% | 227.9 |
|
Cipla
Sept 2025 |
₹107,433.65 Cr | 1342.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.2 |
|
Dr Reddys Laborator…
Sept 2025 |
₹106,457.10 Cr | 1275.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 78.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores